Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758–65. https://doi.org/10.1200/JCO.2008.20.8983.
Article
PubMed
Google Scholar
Kim BH, Park JW. Epidemiology of liver cancer in South Korea. Clin Mol Hepatol. 2018;24(1):1–9. https://doi.org/10.3350/cmh.2017.0112.
Article
CAS
PubMed
Google Scholar
Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol. 2015;26(2):288–300. https://doi.org/10.1093/annonc/mdu210.
Article
CAS
PubMed
Google Scholar
VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, et al. NCCN guidelines insights: older adult oncology, version 2.2016. J Natl Compr Cancer Netw. 2016;14(11):1357–70. https://doi.org/10.6004/jnccn.2016.0146.
Article
Google Scholar
Park J-W, Chen M, Colombo M, Roberts LR, Schwartz M, Chen P-J, et al. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE study. Liver Int. 2015;35(9):2155–66. https://doi.org/10.1111/liv.12818.
Article
PubMed
PubMed Central
Google Scholar
Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–50. https://doi.org/10.1002/hep.29913.
Article
PubMed
Google Scholar
Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–80. https://doi.org/10.1002/hep.29086.
Article
PubMed
Google Scholar
Han K, Kim JH. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. World J Gastroenterol. 2015;21(36):10327–35. https://doi.org/10.3748/wjg.v21.i36.10327.
Article
CAS
PubMed
PubMed Central
Google Scholar
Giannini EG, Moscatelli A, Pellegatta G, Vitale A, Farinati F, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E et al: Application of the intermediate-stage subclassification to patients with untreated hepatocellular carcinoma. Am J Gastroenterol 2016, 111(1):70–77, 1, DOI: https://doi.org/10.1038/ajg.2015.389.
Malagari K, Pomoni M, Moschouris H, Bouma E, Koskinas J, Stefaniotou A, et al. Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis. Cardiovasc Intervent Radiol. 2012;35(5):1119–28. https://doi.org/10.1007/s00270-012-0394-0.
Article
PubMed
Google Scholar
Xia J, Ren Z, Ye S, Sharma D, Lin Z, Gan Y, et al. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol. 2006;59(3):407–12. https://doi.org/10.1016/j.ejrad.2006.03.002.
Article
PubMed
Google Scholar
Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, et al. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol. 2020;55(10):927–43. https://doi.org/10.1007/s00535-020-01711-w.
Article
PubMed
PubMed Central
Google Scholar
Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904(1):437–48. https://doi.org/10.1111/j.1749-6632.2000.tb06498.x.
Article
CAS
PubMed
Google Scholar
Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539–47. https://doi.org/10.1200/JCO.2012.45.2722.
Article
PubMed
Google Scholar
Huffman DM, Barzilai N. Role of visceral adipose tissue in aging. Biochim Biophys Acta. 2009;1790(10):1117–23. https://doi.org/10.1016/j.bbagen.2009.01.008.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kobayashi T, Kawai H, Nakano O, Abe S, Kamimura H, Sakamaki A, et al. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies. BMC Cancer. 2018;18(1):756. https://doi.org/10.1186/s12885-018-4673-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fujita M, Takahashi A, Hayashi M, Okai K, Abe K, Ohira H. Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinoma. Hepatol Res. 2019;49(7):778–86. https://doi.org/10.1111/hepr.13331.
Article
PubMed
Google Scholar
Loosen SH, Schulze-Hagen M, Bruners P, Tacke F, Trautwein C, Kuhl C, et al. Sarcopenia is a negative prognostic factor in patients undergoing Transarterial chemoembolization (TACE) for hepatic malignancies. Cancers (Basel). 2019;11(10):1503. https://doi.org/10.3390/cancers11101503.
Article
CAS
Google Scholar
Long-term care insurance act [https://elaw.klri.re.kr/eng_service/lawView.do?hseq=49788&lang=ENG].
Lee K, Shin Y, Huh J, Sung YS, Lee IS, Yoon KH, et al. Recent issues on body composition imaging for sarcopenia evaluation. Korean J Radiol. 2019;20(2):205–17. https://doi.org/10.3348/kjr.2018.0479.
Article
PubMed
Google Scholar
Llovet JM, Lencioni R. mRECIST for HCC: performance and novel refinements. J Hepatol. 2020;72(2):288–306. https://doi.org/10.1016/j.jhep.2019.09.026.
Article
PubMed
Google Scholar
Vincenzi B, Di Maio M, Silletta M, D'Onofrio L, Spoto C, Piccirillo MC, et al. Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: a literature-based meta-analysis. PLoS One. 2015;10(7):e0133488. https://doi.org/10.1371/journal.pone.0133488.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tovoli F, Renzulli M, Negrini G, Brocchi S, Ferrarini A, Andreone A, et al. Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib. Eur Radiol. 2018;28(9):3611–20. https://doi.org/10.1007/s00330-018-5393-3.
Article
PubMed
Google Scholar
European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease. J Hepatol. 2019;70(1):172–93.
Article
Google Scholar
Chu KKW, Chok KSH. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients? World J Gastroenterol. 2019;25(27):3563–71. https://doi.org/10.3748/wjg.v25.i27.3563.
Article
PubMed
PubMed Central
Google Scholar
Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, et al. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 1996;198(1):33–40. https://doi.org/10.1148/radiology.198.1.8539401.
Article
CAS
PubMed
Google Scholar
Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131(2):461–9. https://doi.org/10.1053/j.gastro.2006.05.021.
Article
CAS
PubMed
Google Scholar
Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35. https://doi.org/10.1016/S1470-2045(08)70153-0.
Article
PubMed
Google Scholar
Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–40. https://doi.org/10.1016/j.jhep.2015.02.031.
Article
CAS
PubMed
Google Scholar
Prado CM, Baracos VE, McCargar LJ, Mourtzakis M, Mulder KE, Reiman T, et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res. 2007;13(11):3264–8. https://doi.org/10.1158/1078-0432.CCR-06-3067.
Article
CAS
PubMed
Google Scholar
Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, et al. Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy. Oncol Lett. 2017;14(2):1637–47. https://doi.org/10.3892/ol.2017.6287.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol. 2016;65(6):1232–44. https://doi.org/10.1016/j.jhep.2016.07.040.
Article
PubMed
PubMed Central
Google Scholar
Roubenoff R. Sarcopenia: effects on body composition and function. J Gerontol A Biol Sci Med Sci. 2003;58(11):1012–7. https://doi.org/10.1093/gerona/58.11.M1012.
Article
PubMed
Google Scholar
Shiraki M, Nishiguchi S, Saito M, Fukuzawa Y, Mizuta T, Kaibori M, et al. Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011. Hepatol Res. 2013;43(2):106–12. https://doi.org/10.1111/hepr.12004.
Article
PubMed
Google Scholar
Kyle UG, Genton L, Hans D, Karsegard L, Slosman DO, Pichard C. Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr. 2001;55(8):663–72. https://doi.org/10.1038/sj.ejcn.1601198.
Article
CAS
PubMed
Google Scholar
Wu CH, Yao WJ, Lu FH, Yang YC, Wu JS, Chang CJ. Sex differences of body fat distribution and cardiovascular dysmetabolic factors in old age. Age Ageing. 2001;30(4):331–6. https://doi.org/10.1093/ageing/30.4.331.
Article
CAS
PubMed
Google Scholar
Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17(4):319–26. https://doi.org/10.1016/j.numecd.2006.07.005.
Article
CAS
PubMed
Google Scholar
Oh TH, Byeon JS, Myung SJ, Yang SK, Choi KS, Chung JW, et al. Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol. 2008;23(3):411–7. https://doi.org/10.1111/j.1440-1746.2007.05125.x.
Article
CAS
PubMed
Google Scholar
Shuster A, Patlas M, Pinthus JH, Mourtzakis M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol. 2012;85(1009):1–10. https://doi.org/10.1259/bjr/38447238.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bauer JM, Sieber CC. Sarcopenia and frailty: a clinician’s controversial point of view. Exp Gerontol. 2008;43(7):674–8. https://doi.org/10.1016/j.exger.2008.03.007.
Article
CAS
PubMed
Google Scholar
Kirkhus L, Šaltytė Benth J, Rostoft S, Grønberg BH, Hjermstad MJ, Selbæk G, et al. Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty. Br J Cancer. 2017;117(4):470–7. https://doi.org/10.1038/bjc.2017.202.
Article
CAS
PubMed
PubMed Central
Google Scholar
Couto OFM, Dvorchik I, Carr BI. Causes of death in patients with Unresectable hepatocellular carcinoma. Dig Dis Sci. 2007;52(11):3285–9. https://doi.org/10.1007/s10620-007-9750-3.
Article
CAS
PubMed
Google Scholar
Guo H, Wu T, Lu Q, Li M, Guo JY, Shen Y, et al. Surgical resection improves long-term survival of patients with hepatocellular carcinoma across different Barcelona clinic liver Cancer stages. Cancer Manag Res. 2018;10:361–9. https://doi.org/10.2147/CMAR.S152707.
Article
PubMed
PubMed Central
Google Scholar
Yang ZW, He W, Zheng Y, Zou RH, Liu WW, Zhang YP, et al. The efficacy and safety of long- versus short-interval transarterial chemoembolization in unresectable hepatocellular carcinoma. J Cancer. 2018;9(21):4000–8. https://doi.org/10.7150/jca.24250.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vitale A, Burra P, Frigo AC, Trevisani F, Farinati F, Spolverato G, et al. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona clinic liver Cancer stages: a multicentre study. J Hepatol. 2015;62(3):617–24. https://doi.org/10.1016/j.jhep.2014.10.037.
Article
PubMed
Google Scholar
Burrel M, Reig M, Forner A, Barrufet M, de Lope CR, Tremosini S, et al. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design. J Hepatol. 2012;56(6):1330–5. https://doi.org/10.1016/j.jhep.2012.01.008.
Article
PubMed
Google Scholar
Keilani M, Hasenoehrl T, Baumann L, Ristl R, Schwarz M, Marhold M, et al. Effects of resistance exercise in prostate cancer patients: a meta-analysis. Support Care Cancer. 2017;25(9):2953–68. https://doi.org/10.1007/s00520-017-3771-z.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu G, Zhang X, Wang Y, Xiong H, Zhao Y, Sun F. Effects of exercise intervention in breast cancer survivors: a meta-analysis of 33 randomized controlled trails. Onco Targets Ther. 2016;9:2153–68. https://doi.org/10.2147/OTT.S97864.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brown JC, Zemel BS, Troxel AB, Rickels MR, Damjanov N, Ky B, et al. Dose-response effects of aerobic exercise on body composition among colon cancer survivors: a randomised controlled trial. Br J Cancer. 2017;117(11):1614–20. https://doi.org/10.1038/bjc.2017.339.
Article
PubMed
PubMed Central
Google Scholar
Parikh ND, Zhang P, Singal AG, Derstine BA, Krishnamurthy V, Barman P, et al. Body composition predicts survival in patients with hepatocellular carcinoma treated with Transarterial chemoembolization. Cancer Res Treat. 2018;50(2):530–7. https://doi.org/10.4143/crt.2017.156.
Article
PubMed
Google Scholar
Imai K, Takai K, Hanai T, Ideta T, Miyazaki T, Kochi T, et al. Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with Sorafenib. Int J Mol Sci. 2015;16(5):9612–24. https://doi.org/10.3390/ijms16059612.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim YR, Park S, Han S, Ahn JH, Kim S, Sinn DH, et al. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Sci Rep. 2018;8(1):7157. https://doi.org/10.1038/s41598-018-25628-w.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yeh WS, Chiang PL, Kee KM, Chang CD, Lu SN, Chen CH, et al. Pre-sarcopenia is the prognostic factor of overall survival in early-stage hepatoma patients undergoing radiofrequency ablation. Medicine (Baltimore). 2020;99(23):e20455. https://doi.org/10.1097/MD.0000000000020455.
Article
PubMed Central
Google Scholar
Lee J, Cho Y, Park S, Kim JW, Lee IJ. Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy. Front Oncol. 2019;9(1075). https://doi.org/10.3389/fonc.2019.01075.
Nishikawa H, Shiraki M, Hiramatsu A, Moriya K, Hino K, Nishiguchi S. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res. 2016;46(10):951–63. https://doi.org/10.1111/hepr.12774.
Article
PubMed
Google Scholar
Heymsfield SB, Peterson CM, Thomas DM, Heo M, Schuna JM Jr. Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes Rev. 2016;17(3):262–75. https://doi.org/10.1111/obr.12358.
Article
CAS
PubMed
Google Scholar
Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7 e302. https://doi.org/10.1016/j.jamda.2019.12.012.
Article
PubMed
Google Scholar